Publications

The influence of a gene expression signature on the diagnosis and recommended treatment of melanocytic tumors by dermatopathologists.

Clay J Cockerell, Jaime Tschen, Bretn Evans, Emily Bess, Jason Kidd, Kathryn A Kolquist, Colleen Rock, Loren E Clarke

Medicine (Baltimore). 2016 Oct;95(40):e4887.

An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi.

Loren E. Clarke, Darl D. Flake II, Klaus Busam, Clay Cockerell, Klaus Helm, Jennifer McNiff, Jon Reed, Jaime Tschen, Jinah Kim, Raymond Barnhill, Rosalie Elenitsas, Victor G. Prieto, Jonathan Nelson, Hillary Kimbrell, Kathryn A. Kolquist, Krystal L. Brown, M. Bryan Warf, Benjamin B. Roa, Richard J. Wenstrup

Cancer. 2016 Oct 21. doi: 10.1002/cncr.30385.

Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma

Loren E. Clarke, M.B. Warf, Darl D. Flake II, Anne-Renee Hartman, Steven Tahan, Christopher R. Shea, Pedram Gerami, Jane Messina, Scott R. Florell, Richard J. Wenstrup, Kristen Rushton, Kirstin M. Roundy, Colleen Rock, Benjamin Roa, Kathryn A. Kolquist, Alexander Gutin, Steven Billings, Sancy Leachman

J Cutan Pathol. 2015 Apr;42(4):244-52. doi: 10.1111/cup.12475. Epub 2015 Apr 13.

Analytical validation of a melanoma diagnostic gene signature using formalin-fixed paraffin-embedded melanocytic lesions

M. Bryan Warf, Darl D. Flake II, Doug Adams, Alexander Gutin, Kathryn A. Kolquist, Richard J. Wenstrup, Benjamin B. Roa

Biomark Med. 2015;9(5):407-16. doi: 10.2217/bmm.15.11. Epub 2015 Mar 27.

Posters

Gene Expression Signature as an Ancillary Method in the Diagnosis of Desmoplastic Melanoma

Loren E. Clarke, MD , Jason D. Pimental , Hillary Z. Kimbrell , Klaus J. Busam MD

ASDP, Oct 2016, Chicago IL

Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes

Jennifer Ko, Balwir Matharoo-Ball, Steven Billings, Brian Thomson, Jean Tang, Kavita Sarin, Emily Cai, Jinah Kim, Colleen Rock, Hillary Kimbrell, Darl Flake, Bryan Warf, Jonathan Nelson, Thaylon Davis, Catherine Miller, Kristen Rushton, Anne-Renee Hartman, Richard Wenstrup, Loren Clarke

ASDP, Oct 2016, Chicago IL

An Independent Validation of a Gene Expression Signature to Differentiate Malignant Melanoma from Benign Melanocytic Nevi

H. Kimbrell, MD; L. E. Clarke, MD; D. D. Flake II, MS; K. Busam, MD; C. Cockerell, MD; K. Helm, MD; J. McNiff, MD; J. Reed, MD; J. Tschen, MD; J. Kim, MD; R. Barnhill, MD; R. Elenitsas, MD; V. G. Prieto, MD ; J. Nelson, BS; K. A. Kolquist, MD; K. L. Brown, PhD; M. B. Warf, PhD; B. B. Roa, PhD; R. J. Wenstrup, MD

USCAP 2016, Mar 2016, Seattle WA

A RETROSPECTIVE STUDY OF THE INFLUENCE OF A GENE EXPRESSION SIGNATURE ON THE TREATMENT OF MELANOCYTIC TUMORS BY DERMATOLOGISTS

Clay J. Cockerell, Jaime Tschen, Steven D. Billings, Colleen Rock, Brent Evans, Loren E. Clarke

AAD, Mar 2015, San Francisco CA

A RETROSPECTIVE STUDY OF THE INFLUENCE OF A GENE EXPRESSION SIGNATURE ON THE TREATMENT OF MELANOCYTIC TUMORS

Colleen Rock, PharmD, PhD; Clay Cockerell, MD; Jaime Tschen, MD; Steven Billings, MD; Brent Evans, MS; John Kidd, MS; Krystal Brown, PhD; Loren E. Clarke, MD

ASDP, Oct 2015, San Francisco CA

A Clinically Validated Gene Expression Score Impacts Diagnosis and Management Recommendations of Melanocytic Lesions by Dermatopathologists

Loren E Clarke, Emily Bess, Brent Evans, John Kidd, Kathryn A Kolquist, Colleen Rock

NCCN, March 2015.

A Clinically Validated Gene Expression Score Impacts Diagnosis and Management Recommendations of Melanocytic Lesions by Dermatopathologists

Loren E Clarke, Emily Bess, Kathryn Kolquist, Brent Evans, Kelsey Moyes, Colleen Rock

CAP 2014, September 2014, Chicago IL. Poster Presentation.

The Influence Of A Gene Expression Signature On The Diagnosis And Recommended Treatment Of Melanocytic Tumors By Dermatopathologists

Loren E Clarke, Emily Bess, Kelsey Moyes, Brent Evans, Kathryn A Kolquist, Colleen Rock

ASCO 2014, May 2014, Chicago, IL. Poster Presentation.

Development And Validation Of A Gene Expression Signature To Distinguish Malignant Melanoma From Benign Nevi

Colleen Rock, Loren E Clarke, M. Bryan Warf, Darl D Flake II, Anne-Renee Hartman, Steven Tahan, Christopher R. Shea, Pedram Gerami, Jane Messina, Richard J. Wenstrup, Kristen Rushton, Kirstin M. Roundy, Benjamin Roa, Kathryn A. Kolquist, Alexander Gutin, Steven D. Billings, Sancy Ann Leachman.

ASCO 2014, May 2014, Chicago, IL. Poster Presentation.

Development of a Gene Expression Signature to Differentiate Malignant Melanoma From Benign Melanocytic Nevi

Loren E. Clarke, Carola Berking, Steven Tahan, Christopher R. Shea, Darl D. Flake II, Alexander Gutin, Kathryn A. Kolquist, Anne-Renee Hartman, Benjamin Roa, and M. Bryan Warf.

Society for Melanoma Research International Congress, November 17-19, 2013, Philadelphia, PA. Poster Presentation.

The Clinical Impact of a Gene Expression Signature That Differentiates Benign Nevi From Malignant Melanoma

Colleen Rock, Steven D. Billings, Klaus J. Busam, David E. Elder, Pedram Gerami, Melissa Gill, Jane L. Messina, Steven R. Tahan, Kelsey Moyes, M. Bryan Warf, Sancy A. Leachman, Loren E. Clarke

United States and Canada Academy of Pathology, March 5, 2014, San Diego, CA. Poster Presentation.